Skip to main content
. Author manuscript; available in PMC: 2021 Apr 23.
Published in final edited form as: Methods Mol Biol. 2018;1678:167–202. doi: 10.1007/978-1-4939-7346-0_10

Fig. 4.

Fig. 4

Covalent viability probe labeling. EL4 cells treated with camptothecin at 5 μM for 16 h or L1210 cells treated with anti-Fas antibody (clone Jo2) at 1:1000 final concentration for 12 h were labeled with the indicated covalent viability probe. Forward versus side scatter dotplots and viability probe histograms are shown for untreated (left two columns) and treated (right two columns) cells